HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Electronic pseudogap-driven formation of new double-perovskite-like borides within the Sc2Ir6-xTxB (T = Pd, Ni; x = 0-6) series.

Abstract
Analysis of the electronic density of states of the hypothetical ternary double-perovskite-like phases "Sc2T6B (T = Ir, Pd, Ni)" reveals the presence of deep and large pseudogaps between 61 and 68 valence electrons (VE) as well as a strong peak at 69 VEs. Subsequently, crystal orbital Hamilton population (COHP) bonding analysis shows that the heteroatomic T-B and Sc-T interactions are optimized in Sc2Ir6B (63 VE) but not in "Sc2Pd6B (69 VE)" and "Sc2Ni6B (69 VE)", thus indicating less stability for these VE-richer phases. These findings point out the possibility of discovering new double-perovskite-like borides through chemical substitution and lead to the study of the Sc2Ir6-xPdxB and Sc2Ir6-xNixB (x = 0-6; VE = 63-69) series, for which powder samples and single crystals were synthesized by arc melting the elements. Superstructure reflections were observed in the powder diffractograms of Sc2Ir6-xPdxB and Sc2Ir6-xNixB for x = 0-5 and VE = 63-68, thereby showing that these phases crystallize in the double-perovskite-like Ti2Rh6B-type structure (space group Fm3̅m, Z = 4). Single-crystal and Rietveld refinement results confirm and extend these findings because Pd (or Ni) is found to mix exclusively with Ir in all quaternary compositions. For x = 6, no superstructure reflections were observed, in accordance with the theoretical expectation for the 69 VE phases.
AuthorsMartin Hermus, Jan P Scheifers, Rachid Touzani, Boniface P T Fokwa
JournalInorganic chemistry (Inorg Chem) Vol. 54 Issue 8 Pg. 4056-63 (Apr 20 2015) ISSN: 1520-510X [Electronic] United States
PMID25848819 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: